공지 : 도쿄증권거래소 JASDAQ 스탠다드 시장 신규 상장 관련 안내

Global Information
회사소개 | 문의 | 비교리스트

세계의 신경변성질환 치료제 시장 분석(2021년) : 코로나19(COVID-19)에 의한 성장과 변화(-2030년)

Neurodegenerative Disorder Therapeutics Global Market Report 2021: COVID-19 Growth And Change To 2030

리서치사 The Business Research Company
발행일 On Demand Report 상품 코드 1028788
페이지 정보 영문 175 Pages
가격
US $ 5,000 ₩ 5,919,000 PDF (Single User License)
US $ 7,500 ₩ 8,878,000 PDF (Site License)
US $ 10,000 ₩ 11,838,000 PDF (Enterprise License)


세계의 신경변성질환 치료제 시장 분석(2021년) : 코로나19(COVID-19)에 의한 성장과 변화(-2030년) Neurodegenerative Disorder Therapeutics Global Market Report 2021: COVID-19 Growth And Change To 2030
발행일 : On Demand Report 페이지 정보 : 영문 175 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계 신경변성질환 치료제(Neurodegenerative Disorder Therapeutics) 시장의 구조와 동향에 대해 분석했으며, 시장의 주요 특징과 구조, 전체적인 시장 규모 및 성장률 동향 전망, 부문별(적응증 유형별, 약제 유형별)/지역별/주요 국가별 상세 동향, 주요 기업 개요, 최근의 주요 동향, 향후 시장 기회 등에 대해 전해드립니다.

목차

제1장 개요

제2장 신경변성질환 치료제 시장의 특징

제3장 신경변성질환 치료제 시장 동향과 전략

제4장 신경변성질환 치료제 시장에 대한 코로나19(COVID-19)의 영향

제5장 신경변성질환 치료제 시장 : 시장 규모 및 성장률

  • 시장 규모(단위 : 10억 달러, 2015-2020년)
    • 시장 성장 촉진요인
    • 시장 성장 억제요인
  • 시장 규모(단위 : 10억 달러, 2020-2025년, 2030년)
    • 시장 성장 촉진요인
    • 시장 성장 억제요인

제6장 신경변성질환 치료제 시장 : 분야별 분석

  • 적응증 유형별 시장 규모(단위 : 10억 달러, 2015-2020년/2020-2025년/2030년)
  • 파킨슨병
  • 알츠하이머병
  • 다발성 경화증
  • 헌팅턴병
  • 기타 유형의 적응증
  • 약제 유형별 시장 규모(단위 : 10억 달러, 2015-2020년/2020-2025년/2030년)
  • N-methyl-D-aspartate Receptor
  • 선택적 세라토닌 재흡수 저해제(SSRI)
  • 도파민 저해제
  • 기타 유형 약제
  • 유통경로별 시장 규모(단위 : 10억 달러, 2015-2020년/2020-2025년/2030년)
  • 병원 약국
  • 소매 약국
  • 온라인 약국

제7장 신경변성질환 치료제 시장 : 지역별/국가별 분석

  • 지역별 시장 규모(단위 : 10억 달러, 2015-2020년/2020-2025년/2030년)
  • 국가별 시장 규모(단위 : 10억 달러, 2015-2020년/2020-2025년/2030년)

제8장 아시아태평양의 신경변성질환 치료제 시장

  • 시장 개요
  • 지역 정보
  • 적응증 유형별 시장 규모(단위 : 10억 달러, 2015-2020년/2020-2025년/2030년)
  • 약제 유형별 시장 규모(단위 : 10억 달러, 2015-2020년/2020-2025년/2030년)

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽의 신경변성질환 치료제 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 동유럽의 신경변성질환 치료제 시장

제20장 러시아 시장

제21장 북미의 신경변성질환 치료제 시장

제22장 미국 시장

제23장 남미의 신경변성질환 치료제 시장

제24장 브라질 시장

제25장 중동의 신경변성질환 치료제 시장

제26장 아프리카의 신경변성질환 치료제 시장

제27장 신경변성질환 치료제 시장 : 경쟁 구도와 기업 개요

  • 경쟁 구도
  • 기업 개요
    • Biogen
    • Pfizer
    • Novartis
    • Sanofi
    • Teva Pharmaceutical

제28장 신경변성질환 치료제 파이프라인 제품 분석

제29장 신경변성질환 치료제 시장의 주요 인수합병(M&A)

제30장 신경변성질환 치료제 시장 : 전망과 잠재력 분석

제31장 부록

LSH 21.09.29

“Neurodegenerative Disorder Therapeutics Global Market Report 2021: COVID-19 Growth And Change to 2030” from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global neurodegenerative disorder therapeutics market.

This report focuses on neurodegenerative disorder therapeutics market which is experiencing strong growth. The report gives a guide to the neurodegenerative disorder therapeutics market which will be shaping and changing our lives over the next ten years and beyond, including the markets response to the challenge of the global pandemic.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Where is the largest and fastest growing market for the neurodegenerative disorder therapeutics? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The Neurodegenerative Disorder Therapeutics market global report” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider neurodegenerative disorder therapeutics market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the COVID-19 virus and forecasting its growth.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The neurodegenerative disorder therapeutics market section of the report gives context. It compares the neurodegenerative disorder therapeutics market with other segments of the neurodegenerative disorder therapeutics market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, neurodegenerative disorder therapeutics indicators comparison.

Scope

Markets Covered:

1) By Indication Type: Parkinson's Disease; Alzheimer's Disease; Multiple Sclerosis; Huntington Disease; Other Indication Types

2) By Drug Type: N- methyl- D- aspartate Receptor; Selective Serotonin Reuptake Inhibitor; Dopamine Inhibitors; Other Drug Types

3) By Distribution: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy

Companies Mentioned: Biogen; Pfizer; Novartis; Sanofi; Teva Pharmaceutical

Countries: Brazil, China, France, Germany, India, Indonesia, Japan, South Korea, Russia, UK, USA, Australia

Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, per capita expenditure.

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Executive Summary

2. Neurodegenerative Disorder Therapeutics Market Characteristics

3. Neurodegenerative Disorder Therapeutics Market Trends And Strategies

4. Impact Of COVID-19 On Neurodegenerative Disorder Therapeutics

5. Neurodegenerative Disorder Therapeutics Market Size And Growth

  • 5.1. Global Neurodegenerative Disorder Therapeutics Historic Market, 2015-2020, $ Billion
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints On The Market
  • 5.2. Global Neurodegenerative Disorder Therapeutics Forecast Market, 2020-2025F, 2030F, $ Billion
    • 5.2.1. Drivers Of The Market
    • 5.2.2. Restraints On the Market

6. Neurodegenerative Disorder Therapeutics Market Segmentation

  • 6.1. Global Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Parkinson's Disease
  • Alzheimer's Disease
  • Multiple Sclerosis
  • Huntington Disease
  • Other Indication Types
  • 6.2. Global Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • N- methyl- D- aspartate Receptor
  • Selective Serotonin Reuptake Inhibitor
  • Dopamine Inhibitors
  • Other Drug Types
  • 6.3. Global Neurodegenerative Disorder Therapeutics Market, Segmentation By Distribution, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

7. Neurodegenerative Disorder Therapeutics Market Regional And Country Analysis

  • 7.1. Global Neurodegenerative Disorder Therapeutics Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 7.2. Global Neurodegenerative Disorder Therapeutics Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

8. Asia-Pacific Neurodegenerative Disorder Therapeutics Market

  • 8.1. Asia-Pacific Neurodegenerative Disorder Therapeutics Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 8.3. Asia-Pacific Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

9. China Neurodegenerative Disorder Therapeutics Market

  • 9.1. China Neurodegenerative Disorder Therapeutics Market Overview
  • 9.2. China Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion
  • 9.3. China Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion

10. India Neurodegenerative Disorder Therapeutics Market

  • 10.1. India Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 10.2. India Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

11. Japan Neurodegenerative Disorder Therapeutics Market

  • 11.1. Japan Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 11.2. Japan Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

12. Australia Neurodegenerative Disorder Therapeutics Market

  • 12.1. Australia Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 12.2. Australia Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

13. Indonesia Neurodegenerative Disorder Therapeutics Market

  • 13.1. Indonesia Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 13.2. Indonesia Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

14. South Korea Neurodegenerative Disorder Therapeutics Market

  • 14.1. South Korea Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 14.2. South Korea Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

15. Western Europe Neurodegenerative Disorder Therapeutics Market

  • 15.1. Western Europe Neurodegenerative Disorder Therapeutics Market Overview
  • 15.2. Western Europe Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 15.3. Western Europe Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

16. UK Neurodegenerative Disorder Therapeutics Market

  • 16.1. UK Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 16.2. UK Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

17. Germany Neurodegenerative Disorder Therapeutics Market

  • 17.1. Germany Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 17.2. Germany Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

18. France Neurodegenerative Disorder Therapeutics Market

  • 18.4. France Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 18.5. France Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

19. Eastern Europe Neurodegenerative Disorder Therapeutics Market

  • 19.1. Eastern Europe Neurodegenerative Disorder Therapeutics Market Overview
  • 19.2. Eastern Europe Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 19.3. Eastern Europe Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

20. Russia Neurodegenerative Disorder Therapeutics Market

  • 20.1. Russia Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 20.2. Russia Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

21. North America Neurodegenerative Disorder Therapeutics Market

  • 21.1. North America Neurodegenerative Disorder Therapeutics Market Overview
  • 21.2. North America Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 21.3. North America Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

22. USA Neurodegenerative Disorder Therapeutics Market

  • 22.1. USA Neurodegenerative Disorder Therapeutics Market Overview
  • 22.2. USA Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 22.3. USA Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

23. South America Neurodegenerative Disorder Therapeutics Market

  • 23.1. South America Neurodegenerative Disorder Therapeutics Market Overview
  • 23.2. South America Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 23.3. South America Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

24. Brazil Neurodegenerative Disorder Therapeutics Market

  • 24.1. Brazil Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 24.2. Brazil Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

25. Middle East Neurodegenerative Disorder Therapeutics Market

  • 25.1. Middle East Neurodegenerative Disorder Therapeutics Market Overview
  • 25.2. Middle East Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 25.3. Middle East Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

26. Africa Neurodegenerative Disorder Therapeutics Market

  • 26.1. Africa Neurodegenerative Disorder Therapeutics Market Overview
  • 26.2. Africa Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 26.3. Africa Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

27. Neurodegenerative Disorder Therapeutics Market Competitive Landscape And Company Profiles

  • 27.1. Neurodegenerative Disorder Therapeutics Market Competitive Landscape
  • 27.2. Neurodegenerative Disorder Therapeutics Market Company Profiles
    • 27.2.1. Biogen
      • 27.2.1.1. Overview
      • 27.2.1.2. Products and Services
      • 27.2.1.3. Strategy
      • 27.2.1.4. Financial Performance
    • 27.2.2. Pfizer
      • 27.2.2.1. Overview
      • 27.2.2.2. Products and Services
      • 27.2.2.3. Strategy
      • 27.2.2.4. Financial Performance
    • 27.2.3. Novartis
      • 27.2.3.1. Overview
      • 27.2.3.2. Products and Services
      • 27.2.3.3. Strategy
      • 27.2.3.4. Financial Performance
    • 27.2.4. Sanofi
      • 27.2.4.1. Overview
      • 27.2.4.2. Products and Services
      • 27.2.4.3. Strategy
      • 27.2.4.4. Financial Performance
    • 27.2.5. Teva Pharmaceutical
      • 27.2.5.1. Overview
      • 27.2.5.2. Products and Services
      • 27.2.5.3. Strategy
      • 27.2.5.4. Financial Performance

28. Neurodegenerative Disorder Therapeutics Pipeline Analysis

29. Key Mergers And Acquisitions In The Neurodegenerative Disorder Therapeutics Market

30. Neurodegenerative Disorder Therapeutics Market Future Outlook and Potential Analysis

31. Appendix

  • 31.1. Abbreviations
  • 31.2. Currencies
  • 31.3. Research Inquiries
  • 31.4. The Business Research Company
  • 31.5. Copyright And Disclaimer
Back to Top
전화 문의
F A Q